Claritev Corp current report, 13 February 2020

Business Context and Reporting Period

This Form 8-K was filed by Churchill Capital Corp III, a special purpose acquisition company, and is dated February 19, 2020, reporting events associated with its initial public offering. The request metadata identifies Claritev Corp, but the filing text identifies Churchill Capital Corp III as the registrant.

Key Financial and Capitalization Metrics

  • The company completed an initial public offering of 110,000,000 units at $10.00 per unit, generating gross proceeds of $1.1 billion.
  • Each unit consists of one share of Class A common stock and one-fourth of one warrant. Each whole warrant permits the holder to purchase one Class A common share at $11.50, subject to adjustment.
  • The underwriters exercised their 10,000,000-unit over-allotment option.
  • The company privately placed 23,000,000 warrants with Churchill Sponsor III LLC at $1.00 per warrant, generating an additional $23 million of gross proceeds.
  • $1.1 billion of IPO proceeds was deposited into a U.S.-based trust account.
  • The filing provides no revenue, operating profit, net income, cash-flow, margin, or debt metrics.

Material Changes and Transaction Terms

  • The IPO and private placement closed on February 19, 2020; the related underwriting and other transaction agreements were dated February 13, 2020.
  • Trust-account proceeds generally remain restricted until completion of an initial business combination, permitted redemptions, or liquidation if no transaction is completed within the applicable deadline.
  • The stated deadline is 24 months after the IPO closing, extendable to 27 months under specified conditions if a business-combination agreement or similar arrangement is in place.
  • Private placement warrants are generally nontransferable until 30 days after completion of the initial business combination and are not redeemable while held by the sponsor or permitted transferees.

Outlook, Risks, and Unusual Items

  • The company is dependent on completing an initial business combination; if it fails to do so within the applicable period, all public shares are subject to redemption, subject to applicable law.
  • Trust-account funds may be used only in limited circumstances before a business combination, including permitted working-capital withdrawals and taxes from interest earned.
  • The filing does not identify a target, provide transaction guidance, or include management forecasts.
  • The filing reports related agreements covering underwriting, warrants, trust administration, registration rights, sponsor services, and director and officer indemnification.

Facts Investors Should Verify

  • Confirm the registrant identity, because the supplied metadata names Claritev Corp while the filing names Churchill Capital Corp III.
  • Verify the IPO closing date, trust-account balance, and the applicable 24- or 27-month business-combination deadline.
  • Review the warrant terms, including the $11.50 exercise price, redemption provisions, and dilution from public and private placement warrants.
  • Review the sponsor, registration-rights, administrative-services, and indemnification agreements filed as exhibits.
  • Assess whether a subsequent filing identifies a business-combination target or changes the redemption and liquidation terms.